TPA
CELG.RT
Trivium Point Advisory’s Bristol-Myers Squibb Company Contingent Value Rights CELG.RT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-10,000
| Closed | -$600 | – | 341 |
|
2024
Q3 | $600 | Buy |
+10,000
| New | +$600 | ﹤0.01% | 327 |
|
2024
Q2 | – | Sell |
-10,000
| Closed | -$550 | – | 301 |
|
2024
Q1 | $550 | Hold |
10,000
| – | – | ﹤0.01% | 218 |
|
2023
Q4 | $900 | Hold |
10,000
| – | – | ﹤0.01% | 200 |
|
2023
Q3 | $852 | Hold |
10,000
| – | – | ﹤0.01% | 189 |
|
2023
Q2 | $1.1K | Hold |
10,000
| – | – | ﹤0.01% | 194 |
|
2023
Q1 | $1.2K | Hold |
10,000
| – | – | ﹤0.01% | 184 |
|
2022
Q4 | $1.18K | Hold |
10,000
| – | – | ﹤0.01% | 186 |
|
2022
Q3 | $2K | Hold |
10,000
| – | – | ﹤0.01% | 185 |
|
2022
Q2 | $1K | Hold |
10,000
| – | – | ﹤0.01% | 201 |
|
2022
Q1 | $2K | Hold |
10,000
| – | – | ﹤0.01% | 225 |
|
2021
Q4 | $2K | Hold |
10,000
| – | – | ﹤0.01% | 247 |
|
2021
Q3 | $2K | Hold |
10,000
| – | – | ﹤0.01% | 227 |
|
2021
Q2 | $2K | Hold |
10,000
| – | – | ﹤0.01% | 218 |
|
2021
Q1 | $2K | Hold |
10,000
| – | – | ﹤0.01% | 197 |
|
2020
Q4 | $4K | Hold |
10,000
| – | – | ﹤0.01% | 181 |
|
2020
Q3 | $4K | Hold |
10,000
| – | – | ﹤0.01% | 164 |
|
2020
Q2 | $4K | Hold |
10,000
| – | – | ﹤0.01% | 156 |
|
2020
Q1 | $5K | Hold |
10,000
| – | – | ﹤0.01% | 141 |
|
2019
Q4 | $5K | Buy |
+10,000
| New | +$5K | ﹤0.01% | 161 |
|